Anna Rull
Impact in
- Clinical Biochemistry top 0.5%
- Paraoxonase enzyme and polymorphisms
- Virology top 2%
- HIV Research and Treatment
Papers in
- Virology 25
- HIV Research and Treatment 25
-
- Paraoxonase enzyme and polymorphisms 16
- Co-authors
- Jorge Joven (53 shared papers)Jordi Camps (49 shared papers)Carlos Alonso‐Villaverde (33 shared papers)Raúl Beltrán‐Debón (39 shared papers)Gerard Aragonès (35 shared papers)Judit Marsillach (21 shared papers)Esther Rodríguez‐Gallego (20 shared papers)Javier Abel Menéndez (10 shared papers)
- Journals
- Journal of Antimicrobial Chemotherapy (8 papers)Atherosclerosis (6 papers)Frontiers in Immunology (6 papers)Scientific Reports (4 papers)EBioMedicine (4 papers)
- Partner nations
- SpainUnited StatesBelgium
In The Last Decade
Anna Rull
108 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 99
- Clinical Biochemistry 393
- Virology 263
- Biochemistry 198
- Emergency Medicine 188
- Pharmacology 144
Countries citing papers authored by Anna Rull
This map shows the geographic impact of Anna Rull's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Rull with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Rull more than expected).
Fields of papers citing papers by Anna Rull
This network shows the impact of papers produced by Anna Rull. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Rull. The network helps show where Anna Rull may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Rull, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 111 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 140 | |
| 2 | 2013 | 140 | |
| 3 | 2010 | 135 | |
| 4 | 2010 | 125 | |
| 5 | 2012 | 115 | |
| 6 | 2021 | 107 | |
| 7 | 2009 | 93 | |
| 8 | 2009 | 93 | |
| 9 | 2009 | 89 | |
| 10 | 2011 | 83 | |
| 11 | 2019 | 64 | |
| 12 | 2021 | 64 | |
| 13 | 2013 | 58 | |
| 14 | 2007 | 57 | |
| 15 | 2005 | 52 | |
| 16 | 2010 | 52 | |
| 17 | 2012 | 51 | |
| 18 | 2012 | 50 | |
| 19 | 2010 | 46 | |
| 20 | 2014 | 45 |
About Anna Rull
Anna Rull is a scholar working on Virology, Clinical Biochemistry, Emergency Medicine, Infectious Diseases and Immunology, having authored 111 papers that have together received 2.9k indexed citations. Recurring topics across this work include HIV Research and Treatment (25 papers), HIV-related health complications and treatments (18 papers), Paraoxonase enzyme and polymorphisms (16 papers), Atherosclerosis and Cardiovascular Diseases (11 papers), Cholesterol and Lipid Metabolism (10 papers), COVID-19 Clinical Research Studies (10 papers), HIV/AIDS drug development and treatment (9 papers) and Liver Disease Diagnosis and Treatment (9 papers). The work is most often cited by research in Clinical Biochemistry (393 citations), Virology (263 citations), Biochemistry (198 citations), Emergency Medicine (188 citations) and Pharmacology (144 citations). Anna Rull has collaborated with scholars based in Spain, United States and Belgium. Frequent co-authors include Jorge Joven, Jordi Camps, Carlos Alonso‐Villaverde, Raúl Beltrán‐Debón, Gerard Aragonès, Judit Marsillach, Esther Rodríguez‐Gallego, Javier Abel Menéndez, Mike Mackness and Bharti Mackness. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Atherosclerosis, Frontiers in Immunology, Scientific Reports and EBioMedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.